GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 12, 2024

Total Value: $3.517B (100.0% shares, 0.0% debt)

Holdings (18)

ALHC ALIGNMENT HEALTHCARE 20.5%

Value $721M Shares 60,993,323 Est. Cost $19.55 Unrealized -51.6%

XP XP, INC 15.1%

Value $531M Shares 29,617,733 Est. Cost $31.26 Unrealized -41.7%

DLO DLOCAL 14.5%

Value $511M Shares 63,906,695 Est. Cost $34.47 Unrealized -77.6%

— SQUARESPACE 14.0%

Value $493M Shares 10,611,073 Est. Cost $59.41 Unrealized —

ALKT ALKAMI 13.9%

Value $490M Shares 15,520,318 Est. Cost $36.66 Unrealized -13.9%

CNTA CENTESSA PHARMACEUTICALS 4.4%

Value $155M Shares 9,681,818 Est. Cost $17.55 Unrealized —

— AKERO THERAPEUTICS 4.3%

Value $150M Shares 5,233,989 Est. Cost $32.57 Unrealized —

PHVS PHARVARIS 4.0%

Value $139M Shares 7,531,252 Est. Cost $22.20 Unrealized -17.7%

EWCZ EUROPEAN WAX CENTER 2.5%

Value $89.15M Shares 13,110,492 Est. Cost $22.36 Unrealized -65.3%

BLND BLEND LABS 2.0%

Value $71.75M Shares 19,132,440 Est. Cost $10.77 Unrealized -69.2%

RPRX ROYALTY PHARMA 1.2%

Value $42.44M Shares 1,500,000 Est. Cost $49.50 Unrealized -44.0%

— THIRD HARMONIC BIO 1.1%

Value $40.09M Shares 2,958,762 Est. Cost $18.97 Unrealized —

IMCR IMMUNOCORE 1.1%

Value $39.28M Shares 1,261,684 Est. Cost $50.86 Unrealized —

RSKD RISKIFIED 0.7%

Value $25.19M Shares 5,324,998 Est. Cost $28.06 Unrealized -80.5%

— ACELYRIN 0.4%

Value $14.25M Shares 2,889,668 Est. Cost $15.74 Unrealized —

Value $3.322M Shares 609,616 Est. Cost $6.58 Unrealized —

GROV GROVE COLLABORATIVE 0.0%

Value $1.264M Shares 936,020 Est. Cost $2.20 Unrealized -35.2%

ADAG ADAGENE 0.0%

Value $586K Shares 264,000 Est. Cost $17.95 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALHC	ALIGNMENT HEALTHCARE	60,993,323	$721M	20.5%	$19.55	-51.6%	COM	01625V104
XP	XP, INC	29,617,733	$531M	15.1%	$31.26	-41.7%	CL A	G98239109
DLO	DLOCAL	63,906,695	$511M	14.5%	$34.47	-77.6%	CL A COM	G29018101
—	SQUARESPACE	10,611,073	$493M	14.0%	$59.41	—	CL A	85225A107
ALKT	ALKAMI	15,520,318	$490M	13.9%	$36.66	-13.9%	COM	01644J108
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$155M	4.4%	$17.55	—	Sponsored ADS	152309100
—	AKERO THERAPEUTICS	5,233,989	$150M	4.3%	$32.57	—	COM	00973Y108
PHVS	PHARVARIS	7,531,252	$139M	4.0%	$22.20	-17.7%	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$89.15M	2.5%	$22.36	-65.3%	CL A COM	29882P106
BLND	BLEND LABS	19,132,440	$71.75M	2.0%	$10.77	-69.2%	CL A	09352U108
RPRX	ROYALTY PHARMA	1,500,000	$42.44M	1.2%	$49.50	-44.0%	SHS CL A	G7709Q104
—	THIRD HARMONIC BIO	2,958,762	$40.09M	1.1%	$18.97	—	COM	88427A107
IMCR	IMMUNOCORE	1,261,684	$39.28M	1.1%	$50.86	—	ADS	45258D105
RSKD	RISKIFIED	5,324,998	$25.19M	0.7%	$28.06	-80.5%	SHS CL A	M8216R109
—	ACELYRIN	2,889,668	$14.25M	0.4%	$15.74	—	COM	00445A100
—	WISH	609,616	$3.322M	0.1%	$6.58	—	CL A	21077C305
GROV	GROVE COLLABORATIVE	936,020	$1.264M	0.0%	$2.20	-35.2%	CL A COM	39957D201
ADAG	ADAGENE	264,000	$586K	0.0%	$17.95	—	ADS	005329107